New hope for advanced lung cancer patients after standard treatments fail
NCT ID NCT07003321
Summary
This study is testing a new oral drug, HRS-4508, for people with advanced non-small cell lung cancer that has stopped responding to standard treatments. It aims to see if the drug can shrink tumors and control the cancer, while closely monitoring its safety. The trial will enroll about 120 adults whose cancer has spread and who have already tried other treatments without success.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Pulmonary Hospital
RECRUITINGShanghai, Shanghai Municipality, 200433, China
Contact
Conditions
Explore the condition pages connected to this study.